CN114432031A - An intravascular hypothermia system - Google Patents
An intravascular hypothermia system Download PDFInfo
- Publication number
- CN114432031A CN114432031A CN202210122407.6A CN202210122407A CN114432031A CN 114432031 A CN114432031 A CN 114432031A CN 202210122407 A CN202210122407 A CN 202210122407A CN 114432031 A CN114432031 A CN 114432031A
- Authority
- CN
- China
- Prior art keywords
- temperature
- cryogenic
- intravascular
- catheter
- low
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002631 hypothermal effect Effects 0.000 title description 22
- 239000002826 coolant Substances 0.000 claims description 4
- 230000003993 interaction Effects 0.000 claims description 4
- 238000009413 insulation Methods 0.000 claims description 2
- 210000000056 organ Anatomy 0.000 abstract description 3
- 230000000004 hemodynamic effect Effects 0.000 abstract description 2
- 230000009123 feedback regulation Effects 0.000 abstract 1
- 206010021113 Hypothermia Diseases 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 206010000891 acute myocardial infarction Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 208000028867 ischemia Diseases 0.000 description 5
- 208000010125 myocardial infarction Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 206010063837 Reperfusion injury Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000009220 hypothermia therapy Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000012947 ischemia reperfusion injury Diseases 0.000 description 2
- 208000023589 ischemic disease Diseases 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 238000013146 percutaneous coronary intervention Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001631 vena cava inferior Anatomy 0.000 description 2
- 230000009471 action Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000002818 limb ischemia Diseases 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000010411 postconditioning Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
- A61B5/6853—Catheters with a balloon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0054—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water
- A61F2007/0056—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water for cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0091—Heating or cooling appliances for medical or therapeutic treatment of the human body inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0095—Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator
- A61F2007/0096—Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator with a thermometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/12—Devices for heating or cooling internal body cavities
- A61F2007/126—Devices for heating or cooling internal body cavities for invasive application, e.g. for introducing into blood vessels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Physiology (AREA)
- Thermal Sciences (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Abstract
Description
技术领域technical field
本发明涉及医疗器械领域,具体而言,涉及一种血管内低温系统。The invention relates to the field of medical devices, in particular to an intravascular hypothermia system.
背景技术Background technique
缺血性疾病是目前影响人类健康的重要疾病,在急性缺血性疾病的治疗中,及时开通罪犯血管,改善缺血器官的血液供应是目前的主要治疗手段。目前此类疾病主要有急性心肌梗死、急性脑梗死、急性肢体缺血。以下以急性心肌梗死为例说明。Ischemic disease is an important disease affecting human health at present. In the treatment of acute ischemic disease, timely opening of culprit vessels and improving blood supply to ischemic organs are the main treatment methods at present. At present, such diseases mainly include acute myocardial infarction, acute cerebral infarction, and acute limb ischemia. The following is an example of acute myocardial infarction.
急性心肌梗死是严重危害人类健康的重要疾病,再灌注治疗是目前治疗心肌梗死的最有效手段,急诊经皮冠状动脉介入治疗是目前的首选治疗方式,可以有效的改善缺血状态,提高了患者的生存率。然而在急性心肌梗死中,有20-50%的心肌损伤来自由缺血再灌注损伤,针对缺血再灌注损伤有相关的大量研究,缺血预适应、后适应、各种药物、辅助治疗等,在动物试验有大量有效的治疗方法,在临床上目前尚没有一种有效的方式应用于临床。Acute myocardial infarction is an important disease that seriously endangers human health. Reperfusion therapy is currently the most effective way to treat myocardial infarction. Emergency percutaneous coronary intervention is currently the preferred treatment method, which can effectively improve the ischemic state and improve patient outcomes. survival rate. However, in acute myocardial infarction, 20-50% of myocardial damage is caused by ischemia-reperfusion injury. There are a lot of studies related to ischemia-reperfusion injury, such as ischemia preconditioning, postconditioning, various drugs, adjuvant therapy, etc. , There are a large number of effective treatment methods in animal experiments, but there is currently no effective way to be used in clinical practice.
亚低温治疗是应用物理或者药物方法把人体的核心温度降至32℃-35℃,低温治疗可以保护心肌功能,促进细胞存活,抑制和减少细胞凋亡。既往研究显示:在一定范围内,心肌温度的下降与心肌梗死面积(每降低1℃心肌梗死危险区域可降低8%)呈线性相关。动物研究显示:治疗性亚低温在减少心肌梗死面积、再灌注损伤、无复流、改善心肌重构、维持心脏功能等方面有着重要作用。因此关于亚低温治疗心肌梗死的研究也在临床上探索,目前在研究的方法有:直接接触身体的冰毯、下腔静脉低温冷却装置、腹膜灌洗的低温装置、冠脉内注入低温盐水的OTW球囊装置。这些装置在动物试验均显示一定的治疗效果,在临床研究中发现其本身特点和副作用,限制其广泛应用。其中前面的全身低温装置需要一定的操作时间,从而影响缺血了时间,并且有颤抖、需要麻醉等全身的副作用。冠脉内的OTW可以作用于局部,然而短时间冠脉内注入生理盐水会加重心脏负荷。因此需要研发一种可以快速作用于局部的低温装置,且不增加心脏负荷。Mild hypothermia therapy is the application of physical or pharmaceutical methods to lower the core temperature of the human body to 32°C-35°C. Hypothermia therapy can protect myocardial function, promote cell survival, and inhibit and reduce apoptosis. Previous studies have shown that, within a certain range, the decrease in myocardial temperature is linearly related to the size of myocardial infarction (each 1 °C reduction in myocardial infarction risk area can reduce by 8%). Animal studies have shown that therapeutic mild hypothermia plays an important role in reducing myocardial infarction size, reperfusion injury, no-reflow, improving myocardial remodeling, and maintaining cardiac function. Therefore, the research on the treatment of myocardial infarction with mild hypothermia is also being explored clinically. The current research methods include: ice blanket directly contacting the body, inferior vena cava hypothermic cooling device, hypothermic device for peritoneal lavage, intracoronary injection of hypothermic saline OTW balloon device. These devices have shown a certain therapeutic effect in animal tests, but their own characteristics and side effects were found in clinical research, which limited their wide application. Among them, the previous whole body cryogenic device requires a certain operation time, which affects the ischemia time, and has systemic side effects such as tremor and anesthesia. Intracoronary OTW can act locally, but a short-term intracoronary infusion of normal saline will increase the cardiac load. Therefore, it is necessary to develop a hypothermic device that can quickly act locally without increasing the burden on the heart.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于提供一种血管内低温系统,以解决以上问题。The purpose of the present invention is to provide an intravascular hypothermia system to solve the above problems.
本发明的实施例是这样实现的:Embodiments of the present invention are implemented as follows:
本发明实施例的一方面,提供一种血管内低温系统,包括:An aspect of the embodiments of the present invention provides an intravascular hypothermia system, comprising:
低温导管,配置有用以感测温度及动压的传感模块;The cryogenic catheter is equipped with a sensing module for sensing temperature and dynamic pressure;
低温发生控制设备,与所述低温导管通过冷源接头连接,所述低温发生控制设备被配置为基于所述传感模块所感测到的温度值和动压值来控制所述血管内低温系统的工作状态。A low temperature generation control device is connected to the cryogenic catheter through a cold source joint, and the low temperature generation control device is configured to control the intravascular cryogenic system based on the temperature value and the dynamic pressure value sensed by the sensing module. working status.
可选地,所述传感模块包括温度传感器和动压传感器。Optionally, the sensing module includes a temperature sensor and a dynamic pressure sensor.
可选地,所述温度传感器设置于所述低温导管的远端,所述动压传感器设置于所述低温导管表面的近中远端。Optionally, the temperature sensor is arranged at the distal end of the cryogenic catheter, and the dynamic pressure sensor is arranged at the proximal, middle and distal end of the surface of the cryogenic catheter.
可选地,所述低温发生控制设备包括控制模块和分别与所述控制模块电连接的人机交互模块以及冷却介质模块。Optionally, the low temperature generation control device includes a control module, a human-computer interaction module and a cooling medium module electrically connected to the control module, respectively.
可选地,所述低温导管包括柔性连接管、手柄和导管细长轴;所述柔性连接管的近端与所述冷源接头的远端连接,所述柔性连接管的远端和所述手柄的近端连接,所述手柄的远端和所述导管细长轴的近端连接。Optionally, the cryogenic catheter comprises a flexible connecting tube, a handle and an elongated shaft of the catheter; the proximal end of the flexible connecting tube is connected with the distal end of the cold source joint, and the distal end of the flexible connecting tube and the The proximal end of the handle is connected, and the distal end of the handle is connected with the proximal end of the elongated shaft of the catheter.
可选地,所述导管细长轴的远端具有低温区域。Optionally, the distal end of the elongated shaft of the catheter has a low temperature region.
可选地,所述低温区域的长度为30-60mm。Optionally, the length of the low temperature region is 30-60 mm.
可选地,所述手柄具有抗压隔热功能。Optionally, the handle has a compression-resistant and heat-insulating function.
本发明提供的血管内低温系统可以用于局部或者全身,实现不同目标器官的低温治疗,并且可以实时检测血流动力学和温度状态进行反馈调节。The intravascular hypothermia system provided by the present invention can be used locally or whole body to realize hypothermia treatment of different target organs, and can detect the hemodynamics and temperature state in real time for feedback adjustment.
附图说明Description of drawings
为了更清楚地说明本发明实施例的技术方案,下面将对实施例中所需要使用的附图作简单地介绍,应当理解,以下附图仅示出了本发明的某些实施例,因此不应被看作是对范围的限定,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他相关的附图。In order to illustrate the technical solutions of the embodiments of the present invention more clearly, the following briefly introduces the accompanying drawings used in the embodiments. It should be understood that the following drawings only show some embodiments of the present invention, and therefore do not It should be regarded as a limitation of the scope, and for those of ordinary skill in the art, other related drawings can also be obtained according to these drawings without any creative effort.
图1为本发明实施例血管内低温系统模块图;FIG. 1 is a block diagram of an intravascular hypothermia system according to an embodiment of the present invention;
图2为图1中血管内低温系统的低温发生控制设备的模块图;FIG. 2 is a block diagram of the low temperature generation control device of the intravascular low temperature system in FIG. 1;
图3为图1中血管内低温系统的低温导管的模块图。FIG. 3 is a block diagram of a cryogenic catheter of the intravascular cryogenic system of FIG. 1 .
具体实施方式Detailed ways
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。通常在此处附图中描述和示出的本发明实施例的组件可以以各种不同的配置来布置和设计。In order to make the purposes, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments These are some embodiments of the present invention, but not all embodiments. The components of the embodiments of the invention generally described and illustrated in the drawings herein may be arranged and designed in a variety of different configurations.
因此,以下对在附图中提供的本发明的实施例的详细描述并非旨在限制要求保护的本发明的范围,而是仅仅表示本发明的选定实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。Thus, the following detailed description of the embodiments of the invention provided in the accompanying drawings is not intended to limit the scope of the invention as claimed, but is merely representative of selected embodiments of the invention. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.
应注意到:相似的标号和字母在下面的附图中表示类似项,因此,一旦某一项在一个附图中被定义,则在随后的附图中不需要对其进行进一步定义和解释。It should be noted that like numerals and letters refer to like items in the following figures, so once an item is defined in one figure, it does not require further definition and explanation in subsequent figures.
在本发明的描述中,需要说明的是,术语“中心”、“上”、“下”、“左”、“右”、“竖直”、“水平”、“内”、“外”等指示的方位或位置关系为基于附图所示的方位或位置关系,或者是该发明产品使用时惯常摆放的方位或位置关系,仅是为了便于描述本发明和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本发明的限制。此外,术语“第一”、“第二”、“第三”等仅用于区分描述,而不能理解为指示或暗示相对重要性。In the description of the present invention, it should be noted that the terms "center", "upper", "lower", "left", "right", "vertical", "horizontal", "inner", "outer", etc. The indicated orientation or positional relationship is based on the orientation or positional relationship shown in the accompanying drawings, or the orientation or positional relationship that the product of the invention is usually placed in use, only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying The device or element referred to must have a particular orientation, be constructed and operate in a particular orientation, and therefore should not be construed as limiting the invention. Furthermore, the terms "first", "second", "third", etc. are only used to differentiate the description and should not be construed as indicating or implying relative importance.
此外,术语“水平”、“竖直”等术语并不表示要求部件绝对水平或悬垂,而是可以稍微倾斜。如“水平”仅仅是指其方向相对“竖直”而言更加水平,并不是表示该结构一定要完全水平,而是可以稍微倾斜。Furthermore, the terms "horizontal", "vertical" and the like do not imply that a component is required to be absolutely horizontal or overhang, but rather may be slightly inclined. For example, "horizontal" only means that its direction is more horizontal than "vertical", it does not mean that the structure must be completely horizontal, but can be slightly inclined.
在本发明的描述中,还需要说明的是,除非另有明确的规定和限定,术语“设置”、“安装”、“相连”、“连接”应做广义理解,例如,可以是固定连接,也可以是可拆卸连接,或一体地连接;可以是机械连接,也可以是电连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通。对于本领域的普通技术人员而言,可以具体情况理解上述术语在本发明中的具体含义。In the description of the present invention, it should also be noted that, unless otherwise expressly specified and limited, the terms "arranged", "installed", "connected" and "connected" should be understood in a broad sense, for example, it may be a fixed connection, It can also be a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection, or an indirect connection through an intermediate medium, or the internal communication between the two components. For those of ordinary skill in the art, the specific meanings of the above terms in the present invention can be understood in specific situations.
请结合参照图1至图3,本实施例提供一种检测血液温度和血液流动状态的低温导管系统,由低温发生控制设备1和低温导管2组成,二者通过冷源接头3连接,其中低温发生控制设备1包括人机交互模块11、控制模块12以及冷却介质模块13,人机交互模块11与控制模块12电连接,控制模块12与冷却介质模块13电连接,低温导管2包括柔性连接管21、手柄22、导管细长轴23和位于导管细长轴23远端的低温区域,柔性连接管21的近端与冷源接头3的远端连接,柔性连接管21的远端和手柄22的近端连接,手柄22的远端和导管细长轴23的近端连接,低温导管2远端设置有温度传感器4,低温导管2表面的近中远端设置有动压传感器5,温度传感器4和动压传感器5与控制模块12电连接。Please refer to FIG. 1 to FIG. 3 , this embodiment provides a cryogenic catheter system for detecting blood temperature and blood flow state. The
该系统在操作时,根据温度传感器4的温度和动压传感器5的安装位置检测血液温度和动压,进而可以高效、直接检测血液灌注组织的血液温度和血液流动状态。During operation, the system detects the blood temperature and dynamic pressure according to the temperature of the
该血管内低温系统在前期试验可以降低冠脉内温度3-6摄氏度。该血管内低温系统为一个三腔结构,三个腔分别记作腔1,腔2和腔3,腔1为了通过导丝,腔2为通低温的介质,腔3为回流回收低温介质;导管前段低温区域为30-60mm,和具有传递温度作用;腔2低温介质和低温导管2前段相通,低温导管2前段与腔3相通,均为单阀门链接;头端为白色部分5mm,增加前段通过性,有温度传感器4;导管前段低温区域前后有动压感受器,也为低温区域的标识点;手柄22处有抗压隔热设计;腔2外接低温介质的接口,腔3外接介质回收装置;动压感受器和温度感受器接控制面板;导管外径1.7-7.0F。The intravascular hypothermia system can reduce the intracoronary temperature by 3-6 degrees Celsius in the preliminary test. The intravascular hypothermia system is a three-lumen structure, and the three lumens are respectively denoted as
低温对缺血再灌注有保护作用,目前装置有其不合理性。目前低温相关的技术有直接接触身体的冰毯、下腔静脉低温冷却装置、腹膜灌洗的低温装置、冠脉内注入低温盐水的OTW球囊装置。低温实现的方式有冰毯、血管内的冰盐水、冠脉内灌注低温生理盐水。目前的低温装置有全身的低温装置,在前已叙述,前面的全身低温装置需要一定的操作时间,从而影响缺血了时间,并且有颤抖、需要麻醉等全身的副作用。冠脉内的OTW可以作用于局部,然而短时间冠脉内注入生理盐水,会加重心脏负荷。该血管内低温系统微创治疗、局部作用、不增加缺血时间、不增加全身副作用。Hypothermia has a protective effect on ischemia-reperfusion, and the current device is unreasonable. The current hypothermia-related technologies include ice blankets that directly contact the body, inferior vena cava cryogenic cooling devices, cryogenic devices for peritoneal lavage, and OTW balloon devices for intracoronary injection of cryogenic saline. Hypothermia can be achieved by ice blankets, intravascular ice saline, and intracoronary perfusion of hypothermic saline. The current cryogenic devices include whole-body cryogenic devices. As mentioned above, the previous whole-body cryogenic devices require a certain operation time, which affects the ischemia time, and has systemic side effects such as tremors and anesthesia. Intracoronary OTW can act locally, but intracoronary infusion of normal saline for a short time will increase the cardiac load. The intravascular hypothermia system has minimally invasive treatment, local action, does not increase ischemia time, and does not increase systemic side effects.
该血管内低温系统使用方法如下,以急性心肌梗死为例,患者在进行急诊PCI时,导丝通过病变到达罪犯血管远端,进行球囊预扩张回复血流,即刻使用低温系统治疗,沿导丝送低温导管2至罪犯血管部位,开启低温系统,血液冲涮低温导管系统可以降低温度到达远端,同时导管远端温度感受器可以感受温度降低情况,观察降温效果,低温区域动压感受器传递压力数据,观察是否有血流通过。根据温度和压力数值,实时调整低温介质的输送压力,低温介质在系统内密闭循环,达到持续降温的效果。低温结束后,关闭低温介质输送系统,撤出低温导管2,进行进一步操作。The intravascular hypothermia system is used as follows. Taking acute myocardial infarction as an example, when the patient undergoes emergency PCI, the guide wire passes through the lesion to the distal end of the culprit vessel, and the balloon is pre-expanded to restore blood flow. Immediately use the hypothermia system for treatment. The cryogenic catheter 2 is sent to the culprit blood vessel by wire, and the cryogenic system is turned on. The blood flushing the cryogenic catheter system can reduce the temperature and reach the distal end. At the same time, the temperature sensor at the distal end of the catheter can sense the temperature decrease and observe the cooling effect. The pressure sensor in the low temperature area transmits pressure. data to see if there is blood flow through. According to the temperature and pressure values, the conveying pressure of the low-temperature medium is adjusted in real time, and the low-temperature medium is closed and circulated in the system to achieve the effect of continuous cooling. After the low temperature is over, the cryogenic medium delivery system is closed, and the cryogenic catheter 2 is withdrawn for further operations.
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and changes. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included within the protection scope of the present invention.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210122407.6A CN114432031A (en) | 2022-02-09 | 2022-02-09 | An intravascular hypothermia system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210122407.6A CN114432031A (en) | 2022-02-09 | 2022-02-09 | An intravascular hypothermia system |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114432031A true CN114432031A (en) | 2022-05-06 |
Family
ID=81372022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210122407.6A Pending CN114432031A (en) | 2022-02-09 | 2022-02-09 | An intravascular hypothermia system |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114432031A (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001043661A2 (en) * | 1999-12-14 | 2001-06-21 | Radiant Medical, Inc. | Method for reducing myocardial infarct by applicaton of intravascular hypothermia |
US20010005791A1 (en) * | 1993-02-10 | 2001-06-28 | Radiant Medical, Inc. | Method and apparatus for regional and whole body temperature modification |
US20020161351A1 (en) * | 1998-09-01 | 2002-10-31 | Samson Wilfred J. | Method and apparatus for treating acute myocardial infarction with selective hypothermic perfusion |
US6607517B1 (en) * | 2001-08-24 | 2003-08-19 | Radiant Medical, Inc. | Method of inotropic treatment of heart disease using hypothermia |
US20050107741A1 (en) * | 2003-11-18 | 2005-05-19 | Martin Willard | Targeted cooling of tissue within a body |
CN104427948A (en) * | 2012-05-22 | 2015-03-18 | 阿坎迪斯有限两合公司 | Medical system for endovascular temperature control of blood, and medical catheter |
CN111419528A (en) * | 2020-04-20 | 2020-07-17 | 首都医科大学宣武医院 | Cryotherapy Catheters and Cryotherapy Systems |
CN212679406U (en) * | 2020-04-20 | 2021-03-12 | 首都医科大学宣武医院 | Cryotherapy Catheters and Cryotherapy Systems |
CN113208803A (en) * | 2021-06-11 | 2021-08-06 | 成都百瑞恒通医疗科技有限公司 | Low-temperature blood vessel protection device |
-
2022
- 2022-02-09 CN CN202210122407.6A patent/CN114432031A/en active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010005791A1 (en) * | 1993-02-10 | 2001-06-28 | Radiant Medical, Inc. | Method and apparatus for regional and whole body temperature modification |
US20020161351A1 (en) * | 1998-09-01 | 2002-10-31 | Samson Wilfred J. | Method and apparatus for treating acute myocardial infarction with selective hypothermic perfusion |
WO2001043661A2 (en) * | 1999-12-14 | 2001-06-21 | Radiant Medical, Inc. | Method for reducing myocardial infarct by applicaton of intravascular hypothermia |
US20020111616A1 (en) * | 1999-12-14 | 2002-08-15 | Radiant Medical, Inc. | Method for reducing myocardial infarct by application of intravascular hypothermia |
US6607517B1 (en) * | 2001-08-24 | 2003-08-19 | Radiant Medical, Inc. | Method of inotropic treatment of heart disease using hypothermia |
US20050107741A1 (en) * | 2003-11-18 | 2005-05-19 | Martin Willard | Targeted cooling of tissue within a body |
CN104427948A (en) * | 2012-05-22 | 2015-03-18 | 阿坎迪斯有限两合公司 | Medical system for endovascular temperature control of blood, and medical catheter |
CN111419528A (en) * | 2020-04-20 | 2020-07-17 | 首都医科大学宣武医院 | Cryotherapy Catheters and Cryotherapy Systems |
CN212679406U (en) * | 2020-04-20 | 2021-03-12 | 首都医科大学宣武医院 | Cryotherapy Catheters and Cryotherapy Systems |
CN113208803A (en) * | 2021-06-11 | 2021-08-06 | 成都百瑞恒通医疗科技有限公司 | Low-temperature blood vessel protection device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lee et al. | Efficacy of radiofrequency ablation for twin-reversed arterial perfusion sequence | |
US7896009B2 (en) | Method for gastric cooling using balloon catheter | |
US6736837B2 (en) | Method for inducing hypothermia for treating neurological disorders | |
US6090132A (en) | Method and apparatus for inducing hypothermia | |
US20040210281A1 (en) | Transesophageal heat exchange catheter for cooling of the heart | |
US6156057A (en) | Method for inducing hypothermia | |
Sessler | Consequences and treatment of perioperative hypothermia | |
US6607517B1 (en) | Method of inotropic treatment of heart disease using hypothermia | |
JP4474590B2 (en) | Local cooling catheter and local cooling device using the same | |
Schwartz et al. | Therapeutic hypothermia for acute myocardial infarction and cardiac arrest | |
US10238533B2 (en) | Gastric, cutaneous, or peritoneal delivery of frozen mist to induce therapeutic hyperthermia | |
US20060190066A1 (en) | System and method for bringing hypothermia rapidly onboard | |
US10420675B2 (en) | Apparatus and method for esophageal cooling | |
JP2014061438A (en) | Therapeutic hypothermia system using endovascular cooling to treat sepsis or septic shock | |
CA2342107A1 (en) | Methods and apparatus for regional and whole body temperature modification | |
US20020045924A1 (en) | Therapeutic modulation of body temperature | |
US20220313484A1 (en) | Apparatus and Methods for Improved Nasal Cavity Treatments | |
CN114432031A (en) | An intravascular hypothermia system | |
US20060200215A1 (en) | System and method for treating cardiac arrest and myocardial infarction | |
CN110522503A (en) | Cryogenic Catheter and Cryogenic Control System | |
US20040215163A1 (en) | Intravascular heat exchange catheter with multiple coolant inlet holes to balloon | |
CN105616060A (en) | Haemorrhoid treatment device | |
Zhou et al. | Enhanced Recovery Concept in Percutaneous Nephrolithotomy | |
Boehm | A Chilling Review of Hypothermia | |
CN115813536A (en) | An ablation catheter with mapping function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220506 |